CDK4 IS CO-AMPLIFIED WITH EITHER TP53 PROMOTER GENE FUSIONS OR MDM2 THROUGH DISTINCT MECHANISMS IN OSTEOSARCOMA

Author(s)

• 

  Karim H. Saba, PhD (he/him/his)

  Associate Researcher
  Lund University
  Lund, Skane Lan, Sweden

  Slides

Co-Author(s)

• 

  Valeria Difilippo, Post-Doc

  Post-Doc
  Lund University
  Lund, Skane Lan, Sweden
• 

  Emelie Styring, MD

  Senior Consultant
  Skåne University Hospital
  Lund, Skane Lan, Sweden
• JN

  Jenny Nilsson, BSc

  Lund University
  Lund, Skane Lan, Sweden
• LM

  Linda Magnusson, MSc

  Lund University
  Lund, Skane Lan, Sweden
• Hv

  Hilda van den Bos, PhD

  University Medical Centre Groningen
  Groningen, Groningen, Netherlands
• DS

  Diana C. J. Spierings, PhD

  University Medical Centre Groningen
  Groningen, Groningen, Netherlands
• 

  Floris Foijer, PhD

  Professor
  University Medical Centre Groningen
  Groningen, Groningen, Netherlands
• MN

  Michaela Nathrath, MD

  Klinikum Kassel
  Kassel, Hessen, Germany
• FH

  Felix Haglund de Flon, MD

  Karolinska University Hospital
  Stockholm, Stockholms Lan, Sweden
• 

  Daniel Baumhoer, MD

  Professor
  University Hospital Basel
  Basel, Basel-Stadt, Switzerland
• 

  Karolin Hansén Nord, PhD

  Senior Lecturer
  Lund University
  Lund, Skane Lan, Sweden